A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A study of the efficacy and safety of the combination of daclatasvir and sofosbuvir in the treatment of hepatitis C virus and HIV coinfection.
Epistemonikos ID: a0f417d7e105aaf1fdb48e5bbf58f8734ebf844d
First added on: Mar 23, 2020